A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University of Nebraska
Dana-Farber Cancer Institute
City of Hope Medical Center
Instituto Nacional de Cancer, Brazil
Melbourne Health
University of Liege
Hospital Israelita Albert Einstein